FeedHome » AAIPharma Announces New Executives in Management Board
AAIPharma Announces New Executives in Management Board
PharmaManufacturing.Com
08/22/2006
AAIPharma Inc. announced the appointment of Mr. Martin Tyson, Senior Vice President of Information Systems and Technology and Dr. Ninad Deshpanday, Vice President of pharmaceutical business development. Mr. Tyson will be responsible for all aspects of the Company’s information systems worldwide. In this role, Dr. Deshpanday will be responsible for all North American business development activities in Pharmaceutical Development, including Analytical, Biotechnology, Formulations Development, GMP Manufacturing and Clinical Trial Materials for both Oral and Parenteral dosage forms. Mr. Tyson will be responsible for all aspects of the Company’s information systems worldwide.
Mr. Tyson brings to AAIPharma over thirty years of pharmaceutical experience designing and managing information technology systems. His experience includes IT systems integration, business process and system reengineering, strategic planning, and the development and deployment of validated systems meeting regulatory requirements worldwide. Earlier in his career, Mr. Tyson held positions of increasing responsibility at Glaxo Wellcome plc (now GlaxoSmithKline). Most recently, he was Senior Vice President and Chief Information Officer for Quintiles Transnational Corp.
Dr. Deshpanday brings over fifteen years experience in pharmaceutical development to AAIPharma. Prior to joining the Company, he was Vice President of Drug Product Development for Synta Pharmaceuticals, with responsibilities for all CM&C activities. Prior to this, he served Cardinal Health as Technical Business Director for the Pharmaceutics division. Previously, Dr. Deshpanday held leadership positions at AAIPharma, including Senior Manager of Formulations Development and Global Product Director of Pharmaceutics.
Mr. Tyson will play a critical role in advancing AAIPharma’s global IT infrastructure. The development of a robust and forward-looking IT operation is of great importance in realizing AAIPharma’s mission to bring innovation and productivity to drug development worldwide,” stated Dr. Ludo Reynders, President and CEO. “Martin’s experience in the pharmaceutical and drug development sector, and his knowledge of market needs and opportunities will be invaluable as AAIPharma sets its course into the future.”
“Dr. Deshpanday possesses a unique combination of leadership skills and technical expertise in pharmaceutical development, and is a great addition to our business development team,” stated Pete Megronigle, Senior Vice President of North American Business Development. “This appointment represents AAIPharma’s continued focus on maximizing technical capabilities with regional effectiveness and broadening its position in the marketplace.”
About AAIPharma
AAIPharma Inc. is a global provider of product development and support services to the pharmaceutical, biotechnology, and medical device industries. From a single test through a range of integrated service offerings, we create value to an industry in search of productivity and innovation. For more information on the Company, please visit AAIPharma's website at www.aaipharma.com.